The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,440.00
Bid: 4,420.00
Ask: 4,540.00
Change: -40.00 (-0.89%)
Spread: 120.00 (2.715%)
Open: 4,500.00
High: 4,500.00
Low: 4,440.00
Prev. Close: 4,480.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on African allegations

8 Oct 2020 17:15

RNS Number : 5632B
Camellia PLC
08 October 2020
 

8 October 2020

Camellia Plc (the "Company")

Update on allegations relating to African operations 

 

As stated in January 2020 and most recently in the interim report in September, Camellia and a number of its subsidiary companies have been put on notice of claims relating to allegations against two companies in its African operations. One of these is Kakuzi Plc in which Camellia bought a controlling stake (50.7%) in the mid-1990s. Kakuzi Plc is quoted on the Nairobi Securities Exchange and is managed by its Board of Directors on behalf of its 1,300 mostly Kenyan shareholders.

Camellia takes any complaint of criminality, misconduct, illegality, or unethical behaviour against its operations very seriously. The allegations are of serious assault, harassment and sexual misconduct allegedly committed by certain individuals apparently employed by the two foreign operating companies. The allegations are being investigated by the two African companies but they are being hindered by UK lawyers Leigh Day's insistence on anonymity.

The two African companies have recognised alternative dispute resolution ("ADR") mechanisms locally so that any allegations are properly examined. If there has been any wrongdoing those responsible will be held to account, and if shortcomings are identified the companies will improve their safeguarding processes and victims will be compensated. Complainants can access independent legal advice, the costs of which will be borne by the operating companies, including if claims fail.

The cost of this ADR process will be expensed in 2020 and in the future and will be in addition to the £4.8m of legal and related costs incurred in 2019 and up to 30 June 2020 as previously disclosed.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Enquiries

Camellia Plc 01622 746655

Tom Franks, CEO

Susan Walker, CFO

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKKFBPPBDDCKK
Date   Source Headline
2nd Jan 20142:42 pmRNSTotal Voting Rights
24th Dec 201311:37 amRNSTransaction in Own Shares
13th Dec 20134:15 pmRNSTransaction in Own Shares
12th Dec 20134:32 pmRNSTransaction in Own Shares
25th Nov 20134:47 pmRNSTransaction in Own Shares
21st Nov 20134:53 pmRNSTransaction in Own Shares
15th Nov 20135:12 pmRNSTransaction in Own Shares
1st Nov 20137:00 amRNSTotal Voting Rights
24th Oct 20137:00 amRNSInterim Management Statement
25th Sep 20133:46 pmRNSShare Transactions
10th Sep 20132:53 pmRNSDirector/PDMR Shareholding
4th Sep 20134:14 pmRNSTransaction in Own Shares
4th Sep 20139:48 amRNSHalf Yearly Report
29th Aug 20137:00 amRNSHalf Yearly Report
1st Jul 20139:57 amRNSTotal Voting Rights
28th Jun 20135:09 pmRNSTransaction in Own Shares
28th Jun 20134:56 pmRNSTransaction in Own Shares
24th Jun 20134:31 pmRNSTransaction in Own Shares
21st Jun 20134:43 pmRNSTransaction in Own Shares
21st Jun 20134:28 pmRNSTransaction in Own Shares
20th Jun 20134:28 pmRNSTransaction in Own Shares
19th Jun 20134:25 pmRNSTransaction in Own Shares
18th Jun 20134:32 pmRNSTransaction in Own Shares
17th Jun 20134:39 pmRNSTransaction in Own Shares
14th Jun 20135:16 pmRNSNotification of Major Interest in Shares
14th Jun 20134:33 pmRNSTransaction in Own Shares
14th Jun 20131:22 pmRNSNotification of Major Interest in Shares
12th Jun 20135:22 pmRNSTransaction in Own Shares
11th Jun 20134:28 pmRNSTransaction in Own Shares - Replacement
11th Jun 201310:45 amRNSTransaction in Own Shares
7th Jun 201310:21 amRNSResult of AGM
7th Jun 201310:12 amRNSRe Joint Venture
6th Jun 201312:30 pmRNSAGM Statement
28th Mar 20137:00 amRNSInterim Management Statement
7th Mar 201312:58 pmRNSDirectorate Change
20th Feb 20132:10 pmRNSNotification of Major Interest in Shares
5th Feb 20133:07 pmRNSNotification of Major Interest in Shares
4th Feb 20132:30 pmRNSNotification of Major Interest in Shares
8th Jan 20131:46 pmRNSDirectorate Change
3rd Jan 201311:16 amRNSDirector/PDMR Shareholding
26th Oct 20123:09 pmRNSRevised Interim Management Statement
26th Oct 20127:00 amRNSInterim Management Statement
3rd Sep 20124:47 pmRNSHalf Yearly Report
30th Aug 20127:00 amRNSHalf Yearly Report
8th Jun 201212:13 pmRNSResult of AGM
7th Jun 201212:17 pmRNSAGM Statement
1st Jun 20129:48 amRNSAnnual Information Update
3rd May 201211:21 amRNSAnnual Report 2011, notice of meeting, proxy form
26th Apr 201212:30 pmRNSFinal Results
30th Mar 20127:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.